Page last updated: 2024-08-24

fluorodopa f 18 and Bone Cancer

fluorodopa f 18 has been researched along with Bone Cancer in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Brixi, H; Cadiot, G; Deguelte, S; Lelièvre, M; Morland, D; Perrier, M; Triumbari, EKA1
He, Q; Shi, X; Wang, X; Zhang, B; Zhang, X1
Addeo, P; Bund, C; Goichot, B; Heimburger, C; Imperiale, A1
Cabria, M; Cistaro, A; Conte, M; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G1
Blanchet, EM; Chen, CC; Herscovitch, P; Martucci, V; Millo, C; Pacak, K1
Chiu, CH; Huang, YY; Liu, CC; Liu, YL; Shiue, CY; Tang, KH; Tsai, CL; Tzen, KY; Wen, HP1
Cascini, G; Cuccurullo, V; Mansi, L; Rossi, A; Rotondo, A; Tamburrini, O1
Fogelman, I; Heinisch, M; Langsteger, W1

Reviews

2 review(s) available for fluorodopa f 18 and Bone Cancer

ArticleYear
Pathophysiological premises to radiotracers for bone metastases.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:4

    Topics: Bone and Bones; Bone Neoplasms; Choline; Dihydroxyphenylalanine; Diphosphonates; Humans; Iodine Radioisotopes; Organometallic Compounds; Organophosphorus Compounds; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Compounds; Technetium Tc 99m Sestamibi

2011
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
    Seminars in nuclear medicine, 2006, Volume: 36, Issue:1

    Topics: Bone Neoplasms; Breast Neoplasms; Choline; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals

2006

Other Studies

6 other study(ies) available for fluorodopa f 18 and Bone Cancer

ArticleYear
Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors.
    Endocrine, 2022, Volume: 78, Issue:2

    Topics: Bone Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors

2022
Recurrent Scapular Metastasis From Hepatoblastoma Shown on FDG PET/CT and F-DOPA PET/CT.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:10

    Topics: Bone Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Recurrence; Scapula

2017
18F-FDOPA Uptake Reflects the Efficacy of Dopamine Agonists Treatment in Pituitary Prolactinoma.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:9

    Topics: Adult; Bone Neoplasms; Dihydroxyphenylalanine; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Positron-Emission Tomography; Prolactinoma; Radiopharmaceuticals

2018
Bone and lymph node metastases from neuroblastoma detected by 18F-DOPA-PET/CT and confirmed by posttherapy 131I-MIBG but negative on diagnostic 123I-MIBG scan.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:1

    Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Dihydroxyphenylalanine; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Tomography, X-Ray Computed

2014
Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on 18F-FLT PET mismatching with central uptake of 18F-FDOPA, 18F-fluorodopamine, and 18F-FDG.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:12

    Topics: Adrenal Gland Neoplasms; Aged; Biological Transport; Bone Neoplasms; Dideoxynucleosides; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Male; Paraganglioma; Positron-Emission Tomography; Radioactive Tracers

2013
Impact of residual (18)F-fluoride in (18)F-FDOPA for the diagnosis of neuroblastoma.
    Annals of nuclear medicine, 2015, Volume: 29, Issue:6

    Topics: Bone Neoplasms; Child; Child, Preschool; Chromatography; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Follow-Up Studies; Humans; Infant; Male; Multimodal Imaging; N-Myc Proto-Oncogene Protein; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging

2015